Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elisa announces its debut Green Bond issuance and a tender offer for its Eurobond maturing 2024

ELISA INSIDE INFORMATION 18 SEPTEMBER 2023 AT 10:45 AMNOT FOR RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, AUSTRALIA, CANADA, HONGKONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SINGAPORE OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.  Elisa announces its debut Green Bond issuance under the company’s EUR 1.5 billion EMTN (Euro Medium Term Note) programme. The issue amount of the new Green Bond issue is expected to be EUR 300 million. The Joint Bookrunners for the proposed issuance are

Commerzbank Aktiengesellschaft EUR Benchmark Green Callable Non-Preferred Senior Fixed-to-Floating Interest Rate Notes due 2029

Pre-Stabilisation Notice   September 18, 2023   Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.     Commerzbank Aktiengesellschaft EUR Benchmark Green Callable Non-Preferred Senior Fixed-to-Floating Interest Rate Notes due 2029 Launched pursuant to the Issuer’s MTN Programme, dated 02 June 2023 as supplemented 27 June 2023 and 18 August 2023     Commerzbank AG (contact: Ian Turner; telephone: +44-207-7475-1817) hereby announces, as Stabilisation Coordinator,

Correction: Repurchase of Truecaller B shares in week 37, 2023

This is a correction of the press release sent out this morning where weighed average share price per day was incorrect for certain days. Information has been corrected below.During 11 September 2023 and 15 September 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 429,902 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.   The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024

TOMRA: New Head of Collection appointed

Marius Fraurud has been appointed the new EVP Head of Collection in TOMRA. Marius has held various leadership roles within Collection since joining the company in 2016 as Head of Research and Development, where he played an instrumental role in the development of TOMRA’s multi-feed technology for reverse vending machines (RVMs). Most recently, Marius has been SVP Head of Europe, Middle East & Africa (EMEA) in Collection with focus on commercially expanding and preparing new markets for deposit return systems (DRS). Marius holds a master's degree in Electronic Engineering from the Norwegian

poLight ASA - share capital increase registered

Reference is made to the stock exchange announcement on 7 September 2023 regarding a decision by the Board of Directors of poLight ASA to increase the share capital following exercise of share options. The share capital increase has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 1,933.20 through issuance of 48,330 new shares, each with a par value of NOK 0.04. The new share capital is thus NOK 2,648,461.92 divided by 66,211,548 shares, each with a par value of NOK 0.04.

Scandinavian ChemoTech signs distribution agreement for Chile with Lambertis Corporation SA

ChemoTech has today signed a distribution agreement with Lambertis Corporation SA "Lambertis" in Chile, which means that ChemoTech is now going to start the process of introducing the IQwave™ and its TSE technology to the first country in South America.Chile, with its approximately 19.631.721 inhabitants (2023), has a well-developed health care system and insurance scheme where currently, 68% of the population is covered by the public fund and 18% by private companies. Cancer is the second leading cause of death[1] and Chile has an adjusted incidence rate of 226 per 100,000 in men and 180

Nomination Committee appointed for AGM 2024 in Rottneros AB

The Annual General Meeting in Rottneros AB (publ) (“Rottneros”) will be held on Wednesday, 20 March 2024, in Sunne. The Nomination Committee has been appointed.In accordance with the guidelines decided at Rottneros Annual General Meeting 2023, the Nomination Committee has been appointed for the Annual General Meeting 2024. The Nominating Committee shall consist of the Chairman of the Board and two additional members. The Chairman of the Board shall not chair the Committee. One of these two members, in addition to the Chairman of the Board, shall be appointed by the company’s largest

Solwers appoints Teemu Kraus as the new CFO

Solwers Plc, Company release September 18, 2023, at 10:00 am Teemu Kraus (M.Sc.) has been appointed Solwers Group’s Chief Financial Officer and a member of the management team as of today, September 18, 2023. In the position, he is comprehensively responsible for the group’s financial management and reporting. Roger Lindqvist, previously the group’s CFO, is moving into an expert position within the organisation.    "We warmly welcome Teemu to continue Roger’s meritorious work in organising and developing the group’s financial management,” says CEO Stefan Nyström.

Saab Secures U.S. AT4 and Carl-Gustaf Ammunition Order

The U.S. Department of Defense (DoD) has expanded a current framework agreement with Saab for AT4 systems and Carl-Gustaf® ammunition. A new order has also been signed valued at USD 104.9 million with deliveries during 2024-2026.The Indefinite Delivery, Indefinite Quantity (IDIQ) framework agreement was originally signed in 2019. The extension will allow the U.S. customer to place orders of Saab’s world-leading close combat solutions for up to an additional USD 422 million.The new order within the framework agreement includes AT4CS RS systems and the latest high explosive round for Carl-

DOF Group ASA – Contract award

DOF is proud to announce three new service contracts with Petrobras. The contracts were originated by a competitive bid process won by DOF and include work within our core service lines for Survey and Inspection. These contracts represent a continuation of the services handled by DOF on the PIDF123 contracts signed with Petrobras in 2020 and under operation since December of that year. At least three vessels shall be utilised to perform flexible pipeline, risers and subsea equipment inspection in Campos Basin, Santos Basin, and Espírito Santos Basin. More than 3,200 inspections are

Repurchase of Truecaller B shares in week 37, 2023

During 11 September 2023 and 15 September 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 429,902 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”.   On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up

Share buy-back programme status

Company announcement no. 21/202318 September 2023   The board of directors initiated a share buy-back programme on 28 June 2023 to be conducted in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules (see company announcement 11/2023 ). Under this programme Wirtek will acquire up to a total of 60,000 shares, corresponding to 0.78% of

Katarina Lundqvist assumes role as Interim CFO at Clinical Laserthermia Systems

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) announces today that Katarina Lundqvist assumes the role as Interim CFO at CLS as of 18 September, taking over from Rolf Ho Bornschein who resigned earlier in September. Katarina Lundqvist has extensive experience from finance director roles in international, pharmaceutical and medtech companies.Katarina Lundqvist assumes the role as Interim CFO as of 18 September 2023. As announced on 8 September, Rolf Ho Bornschein has decided to leave his role as CFO at CLS. He will remain with the company during his notice period, or no longer

Gapwaves and NXP collaborate on high performance radar system solution

Gothenburg, September 18, 2023: Gapwaves today announces a new collaboration with NXP® Semiconductors, the market leader for automotive radar semiconductors. Together the companies will develop 3D waveguide antenna solutions based on NXP’s SAF85xx, an industry-first 28nm RFCMOS radar one-chip IC for next generation ADAS and autonomous driving systems, and Gapwaves proprietary waveguide antenna technology. The collaboration aims to enable unprecedented levels of radar detection range and Field of View (FoV) performance.NXP is a world leading manufacturers of semiconductors for the automotive,

Last day of trading in warrants of series TO 8 in Expres2ion Biotechnologies is today, 18 September 2023

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, 18 September 2023 - Today, 18 September 2023, is the last day of trading in warrants of series TO 8 (the "Warrants"). The exercise period for the Warrants runs up to and including 21 September 2023. One (1) Warrant

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 18 September 2023 at 9.30 a.m. (EEST) Sitowise Group Plc (the "Company") has on 15 September 2023 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley & Co. International plc, according to which Morgan Stanley & Co. International plc's holding of the shares and votes of the Company increased to 5.83 percent on 14 September 2023. According to the notification, Morgan Stanley & Co. International plc holds indirectly a total of 1,840,730 shares corresponding to 5.16 percent

BioStock: Iconovo makes progress in the outlicensing process for ICOpre

Iconovo is approaching the out-licensing of the inhaler ICOpre by now actively seeking contact with potential partners. The company is collaborating with investment bank Stifel to maximise business value and several international pharmaceutical companies have already expressed interest through confidential disclosure agreements.Read the full article at biostock.se: https://www.biostock.se/en/2023/09/iconovo-makes-progress-in-the-outlicensing-process-for-icopre/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Insider information: Pihlajalinna’s and Fennia’s co-operation continues

Pihlajalinna Plc               Insider information               18 September 2023 at 9:15 a.m. Insider information: Pihlajalinna’s and Fennia’s co-operation continues Pihlajalinna Plc and the insurance specialist Fennia deepen the partnership and have signed a new co-operation agreement today, 18 September 2023. Through collaboration, effective and high-quality healthcare services will continue to be offered to Fennia’s customers within Pihlajalinna’s operating network and remote channels. Pihlajalinna remains the main partner for Fennia in the coming four-year period from 2024 to

Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

Aiforia Technologies Plc, Press Release, 18 September 2023 at 09:00 a.m. EEST. Aiforia has designed and implemented its security practices to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA).Additionally, an independent audit firm has evaluated and tested the controls identified by Aiforia for compliance with the HIPAA Security Rule. HIPAA compliance allows Aiforia to offer AI-supported image analysis solutions to a broader range of customers in the US.   "HIPAA compliance allows us to host the cloud environment and maintain patient data on behalf of

Boliden inaugurates sustainability park close to Aitik

In order to strengthen biodiversity and create accessible nature experiences for the public, Boliden is today inaugurating the Sarkanenä Sustainability Park close to Aitik. The company’s aim is for additional sustainability parks to be introduced in connection with active or decommissioned sites. “Mines inevitably have an impact on the environment and the local community in which mining takes place. However, by restoring the land or setting aside other land and initiating efforts to promote biodiversity, we can strengthen the overall natural values and contribute to long-term solutions

Handelsbanken earns top marks for customer satisfaction in all its home markets

Handelsbanken once again has the most satisfied customers among the major banks in Sweden*, receiving top marks from both personal and corporate banking customers in all its home markets. This is the result of the latest annual survey carried out by Swedish Quality Index/EPSI, SKI Bank 2023. “Personal meetings and long-term relationships create the stability that today’s banking customers expect and demand. These results serve as a confirmation that our way of running a bank adds genuine value for our customers,” comments Michael Green, Head of Handelsbanken Sweden.Handelsbanken is top

OssDsign® Catalyst receives clearance from FDA for major new indication for use in interbody cages

Uppsala, Sweden, September 18, 2023. OssDsign AB (publ.) today announces that the company’s innovative nanosynthetic bone graft OssDsign Catalyst has received clearance for use in interbody cages in spinal surgery from the U.S. Food and Drug Administration (FDA), allowing surgeons to use OssDsign Catalyst on-label in any interbody cage cleared for use with synthetic bone grafts. OssDsign Catalyst is the first synthetic bone graft to be cleared to market for interbody use based on bone graft data alone.“This decision by the FDA represents one of the most important events in the history of

Orexo submits New Drug Application to FDA for OX124, a high-dose rescue medication for opioid overdose

· OX124 is based on Orexo´s world-class drug delivery platform amorphOX® and is designed to reverse the effect of the most powerful synthetic opioids, such as fentanyl · Synthetic opioids are behind 91 percent of all fatal opioid overdoses in the US[1] · If approved, US launch is expected to be initiated late in H2 2024 or early 2025   Uppsala, Sweden – September 18, 2023 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces the submission of the New Drug Application (NDA) to the US Food and Drug Administration (FDA) for OX124, a high-dose rescue medication for opioid

There are no items matching the current filter
There are no more items matching the current filter
Back to top